Loading
The first national cancer estimate for China built from population registries, projecting about 4.3 million new cancer cases in 2015, with lung cancer the most common cancer and leading cause of cancer death, and stomach, oesophageal and liver cancers far more prominent than in Western countries.
Chen and colleagues at China's National Cancer Center used data from 72 local population-based cancer registries covering 2009 to 2011, about 6.5% of the population, to project cancer incidence and mortality in China for 2015. They estimated about 4.3 million new cases and 2.8 million deaths. Lung cancer was the most common cancer and the leading cause of death, followed by stomach, oesophageal, liver and colorectal cancers, and the report documented rising incidence in cities alongside higher mortality in rural areas, as well as a large burden of infection-related cancers.
China accounts for roughly a quarter of the world's cancer cases, and this paper is the reference that made its burden legible internationally. It explains why Chinese trial programmes and drug pipelines concentrate on lung, stomach, oesophageal and liver cancers.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Cancer registries and population surveillance, Hepatocellular carcinoma.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, Non-small-cell lung cancer.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.